Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial-Reference-Cited by-同舟云学术

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

Published:2019-10 Issue:10208 Volume:394 Page:1519-1529
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Matthews David R,Paldánius Päivi M,Proot Pieter,Chiang YannTong,Stumvoll Michael,Del Prato Stefano

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2018

2. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm—2019 executive summary;Garber;Endocr Pract,2019

3. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people;Khunti;Diabetes Care,2013

4. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);Lancet,1998

5. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the Diabetes & Aging Study);Laiteerapong;Diabetes Care,2019

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial;Diabetes & Metabolism Journal;2024-09-30

2. Sitagliptin is a time-tested leading drug in the treatment of type 2 diabetes;Meditsinskiy sovet = Medical Council;2024-09-02

3. Metformin decelerates aging clock in male monkeys;Cell;2024-09

4. Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2024-08-27

5. Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management;Diabetologia;2024-08-19